Búsqueda | Biblioteca Virtual en Salud

1.

Approaches to asthma management. Realities and recommendations.

Kemp, J P.

Arch Intern Med ; 153(7): 805-12, 1993 Apr 12.

Artículo en Inglés | MEDLINE | ID: mdl-8466374

2.

Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.

Bronsky, E A; Kemp, J P; Zhang, J; Guerreiro, D; Reiss, T F.

Clin Pharmacol Ther ; 62(5): 556-61, 1997 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9390112

3.

Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children.

Meltzer, E O; Kemp, J P; Orgel, H A; Izu, A E.

Pediatrics ; 69(3): 340-5, 1982 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-7063290

4.

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma.

Kemp, J P.

Drugs ; 59 Suppl 1: 23-28; discussion 43-5, 2000.

Artículo en Inglés | MEDLINE | ID: mdl-10741879

5.

Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.

Pinnas, J L; Bhatt, B D; Campbell, S C; Kemp, J P; Tinkelman, D G.

Chest ; 91(4): 533-9, 1987 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-3549173

6.

Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma.

Nelson, H; Kemp, J P; Bieler, S; Vaughan, L M; Hill, M R.

Chest ; 115(2): 329-35, 1999 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10027428

7.

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.

Kemp, J P; Minkwitz, M C; Bonuccelli, C M; Warren, M S.

Chest ; 115(2): 336-42, 1999 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10027429

8.

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.

Bronsky, E A; Kemp, J P; Orgel, H A; Bierman, C W; Tinkelman, D G; van As, A; Liddle, R F.

Chest ; 105(4): 1032-7, 1994 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-7909285

9.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal, R R; Busse, W W; Kemp, J P; Baker, J W; Kalberg, C; Emmett, A; Rickard, K A.

Chest ; 116(3): 595-602, 1999 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10492259

10.

Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol.

Repsher, L H; Anderson, J A; Bush, R K; Falliers, C J; Kass, I; Kemp, J P; Reed, C; Siegel, S; Webb, D R.

Chest ; 85(1): 34-8, 1984 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-6360573

11.

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

Fish, J E; Kemp, J P; Lockey, R F; Glass, M; Hanby, L A; Bonuccelli, C M.

Clin Ther ; 19(4): 675-90, 1997.

Artículo en Inglés | MEDLINE | ID: mdl-9377612

12.

Role of leukotriene receptor antagonists in pediatric asthma.

Kemp, J P.

Pediatr Pulmonol ; 30(2): 177-82, 2000 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10922143

13.

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.

Bernstein, D I; Berkowitz, R B; Chervinsky, P; Dvorin, D J; Finn, A F; Gross, G N; Karetzky, M; Kemp, J P; Laforce, C; Lumry, W; Mendelson, L M; Nelson, H; Pearlman, D; Rachelefsky, G; Ratner, P; Repsher, L; Segal, A T; Selner, J C; Settipane, G A; Wanderer, A; Cuss, F M; Nolop, K B; Harrison, J E.

Respir Med ; 93(9): 603-12, 1999 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10542973

14.

Safety and clinical efficacy of zileuton in patients with chronic asthma.

Lazarus, S C; Lee, T; Kemp, J P; Wenzel, S; Dubé, L M; Ochs, R F; Carpentier, P J; Lancaster, J F.

Am J Manag Care ; 4(6): 841-8, 1998 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-10181070

15.

Leukotriene receptor antagonists for the treatment of asthma.

Kemp, J P.

IDrugs ; 3(4): 430-41, 2000 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-16100699

16.

A comparative tolerance study of terfenadine-pseudoephedrine combination tablets and pseudoephedrine tablets in patients with allergic or vasomotor rhinitis.

Stroh, J E; Ayars, G H; Bernstein, I L; Kemp, J P; Podleski, W K; Prenner, B M; Schoenwetter, W F; Salzmann, J K.

J Int Med Res ; 16(6): 420-7, 1988.

Artículo en Inglés | MEDLINE | ID: mdl-2906887

17.

Special considerations in the treatment of seasonal allergic rhinitis in adolescents: the role of antihistamine therapy.

Kemp, J P.

Clin Pediatr (Phila) ; 35(8): 383-9, 1996 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-8862897

18.

Allergy in children.

Welch, M J; Kemp, J P.

Prim Care ; 14(3): 575-89, 1987 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-3313463

19.

Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.

Kemp, J P; Korenblat, P E; Scherger, J E; Minkwitz, M.

J Fam Pract ; 48(6): 425-32, 1999 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-10386485

20.

Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females.

Deere, K; Sayers, A; Viljakainen, H T; Lawlor, D A; Sattar, N; Kemp, J P; Fraser, W D; Tobias, J H.

J Clin Endocrinol Metab ; 98(6): E1041-9, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-23533224

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Approaches to asthma management. Realities and recommendations.

Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.

Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children.

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma.

Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.

Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma.

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol.

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

Role of leukotriene receptor antagonists in pediatric asthma.

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.

Safety and clinical efficacy of zileuton in patients with chronic asthma.

Leukotriene receptor antagonists for the treatment of asthma.

A comparative tolerance study of terfenadine-pseudoephedrine combination tablets and pseudoephedrine tablets in patients with allergic or vasomotor rhinitis.

Special considerations in the treatment of seasonal allergic rhinitis in adolescents: the role of antihistamine therapy.

Allergy in children.

Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.

Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females.